DEF 14C

INFORMATION STATEMENT

Company: Sunshine Biopharma Inc.
Filed: June 23, 2015
Period of Report: June 25, 2015
Accession Number: 0001354488-15-003112

View Document ↗ View on SEC.gov ↗